Universität zu Köln

Journal Article

Applebaum, Mark A., Vaksman, Zalman, Hungate, Eric, Henderson, Tara O., London, Wendy B., Pinto, Navin R., Volchenboum, Samuel Louis, Park, Julie R., Naranjo, Arlene, Pearson, Andrew D. J., Hero, Barabara, Cohn, Susan Lerner and Diskin, Sharon (2016). Second malignancies in patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Applebaum, Mark A., Vaksman, Zalman, Lee, Sang Mee, Hungate, Eric A., Henderson, Tara O., London, Wendy B., Pinto, Navin, Volchenboum, Samuel L., Park, Julie R., Naranjo, Arlene, Hero, Barbara, Pearson, Andrew D., Stranger, Barbara E., Cohn, Susan L. and Diskin, Sharon J. (2017). Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project. Eur. J. Cancer, 72. S. 177 - 186. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Bagatell, Rochelle, McHugh, Kieran, Naranjo, Arlene, Van Ryn, Collin, Kirby, Chaim, Brock, Penelope, Lyons, Karen A., States, Lisa J., Rojas, Yesenia, Miller, Alexandra, Volchenboum, Sam L., Simon, Thorsten, Krug, Barbara, Sarnacki, Sabine ORCID: 0000-0003-4304-5578, Valteau-Couanet, Dominique, von Schweinitz, Dietrich, Kammer, Birgit, Granata, Claudio ORCID: 0000-0003-3072-4096, Pio, Luca ORCID: 0000-0002-3776-9994, Park, Julie R. and Nuchtern, Jed (2016). Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study. J. Clin. Oncol., 34 (7). S. 740 - 749. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Burchill, Susan A., Beiske, Klaus, Shimada, Hiroyuki, Ambros, Peter F. ORCID: 0000-0002-5507-7211, Seeger, Robert, Tytgat, Godelieve A. M., Brock, Penelope R., Haber, Michelle ORCID: 0000-0003-2036-8817, Park, Julie R. and Berthold, Frank (2017). Recommendations for the Standardization of Bone Marrow Disease Assessment and Reporting in Children With Neuroblastoma on Behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group. Cancer, 123 (7). S. 1095 - 1106. HOBOKEN: WILEY. ISSN 1097-0142

Depuydt, Pauline, Boeva, Valentina ORCID: 0000-0002-4382-7185, Hocking, Toby D., Cannoodt, Robrecht ORCID: 0000-0003-3641-729X, Ambros, Inge M., Ambros, Peter F. ORCID: 0000-0002-5507-7211, Asgharzadeh, Shahab, Attiyeh, Edward F., Combaret, Valerie, Defferrari, Raffaella, Fischer, Matthias, Hero, Barbara, Hogarty, Michael D., Irwin, Meredith S., Koster, Jan ORCID: 0000-0002-0890-7585, Kreissman, Susan, Ladenstein, Ruth, Lapouble, Eve, Laureys, Genevieve, London, Wendy B., Mazzocco, Katia ORCID: 0000-0002-6599-5681, Nakagawara, Akira, Noguera, Rosa, Ohira, Miki, Park, Julie R., Poetschger, Ulrike, Theissen, Jessica, Tonini, Gian Paolo, Valteau-Couanet, Dominique, Varesio, Luigi, Versteeg, Rogier ORCID: 0000-0001-7172-0388, Speleman, Frank, Maris, John M., Schleiermacher, Gudrun and De Preter, Katleen (2018). Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients. JNCI-J. Natl. Cancer Inst., 110 (10). CARY: OXFORD UNIV PRESS INC. ISSN 1460-2105

London, Wendy B., Moroz, Veronica, Hero, Barabara, Park, Julie R., Valteau-Couanet, Dominique, Nakagawara, Akira, Berthold, Frank, Matthay, Katherine K., Schleiermacher, Gudrun, Pearson, Andrew D. J., Cohn, Susan Lerner and Machin, David (2014). A neuroblastoma risk classification model for developing countries: A study from the International Neuroblastoma ( NB) Risk Group (INRG) database. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Meany, Holly J., London, Wendy B., Ambros, Peter F., Matthay, Katherine K., Monclair, Tom, Simon, Thorsten, Garaventa, Alberto ORCID: 0000-0002-5368-6363, Berthold, Frank, Nakagawara, Akira, Cohn, Susan L., Pearson, Andrew D. J. and Park, Julie R. (2014). Significance of Clinical and Biologic Features in Stage 3 Neuroblastoma: A Report from the International Neuroblastoma Risk Group Project. Pediatr. Blood Cancer, 61 (11). S. 1932 - 1940. HOBOKEN: WILEY. ISSN 1545-5017

Moreno, Lucas, Barone, Giuseppe, DuBois, Steven G., Molenaar, Jan, Fischer, Matthias, Schulte, Johannes, Eggert, Angelika ORCID: 0000-0003-3476-8184, Schleiermacher, Gudrun, Speleman, Frank, Chesler, Louis, Geoerger, Birgit, Hogarty, Michael D., Irwin, Meredith S., Bird, Nick, Blanchard, Guy B., Buckland, Sean, Caron, Hubert, Davis, Susan, De Wilde, Bram, DeubZer, Hedwig E., Dolman, Emmy, Eilers, Martin, George, Rani E., George, Sally, Sterba, Jaroslav, Maris, John M., Marshall, Lynley, Merchant, Melinda, Mortimer, Peter, Owens, Cormac, Philpott, Anna, Poon, Evon, Shay, Jerry W., Tonelli, Roberto, Valteau-Couanet, Dominique, Vassal, Gilles, Park, Julie R. and Pearson, Andrew D. J. (2020). Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. Eur. J. Cancer, 136. S. 52 - 69. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Park, Julie R., Bagatell, Rochelle, Cohn, Susan L., Pearson, Andrew D., Villablanca, Judith G., Berthold, Frank, Burchill, Susan, Boubaker, Ariane, McHugh, Kieran, Nuchtern, Jed G., London, Wendy B., Seibel, Nita L., Lindwasser, O. Wolf, Maris, John M., Brock, Penelope, Schleiermacher, Gudrun, Ladenstein, Ruth, Matthay, Katherine K. and Valteau-Couanet, Dominique (2017). Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting. J. Clin. Oncol., 35 (22). S. 2580 - 2593. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Park, Julie R., Villablanca, Judith G., Hero, Barbara, Kushner, Brian H., Wheatley, Keith, Beiske, Klaus H., Ladenstein, Ruth L., Baruchel, Sylvain, Macy, Margaret E., Moreno, Lucas, Seibel, Nita L., Pearson, Andrew D., Matthay, Katherine K. and Valteau-Couanet, Dominique (2022). Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Cancer, 128 (21). S. 3775 - 3784. HOBOKEN: WILEY. ISSN 1097-0142

Pinto, Navin R., Applebaum, Mark A., Volchenboum, Samuel L., Matthay, Katherine K., London, Wendy B., Ambros, Peter F., Nakagawara, Akira, Berthold, Frank, Schleiermacher, Gudrun, Park, Julie R., Valteau-Couanet, Dominique, Pearson, Andrew D. J. and Cohn, Susan L. (2015). Advances in Risk Classification and Treatment Strategies for Neuroblastoma. J. Clin. Oncol., 33 (27). S. 3008 - 3019. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755